Clinical Trials

Phase 3 Active not recruiting

Breast Neoplasms

NCT06745024 2026-04-08

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

280 enrolled

Neoplasm Metastasis

NCT06958328 2026-04-08

LAP100

356 enrolled

Pancreatic Neoplasms

NCT05812807 2026-04-07

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

1,295 enrolled

Phase 2 Not yet recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT07513324 2026-04-07

Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)

116 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05873608 2026-04-06

Communication Issues in Patient and Provider Discussions of Immunotherapy

Phase NA Recruiting

125 enrolled

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT05483374 2026-04-03

EURACAN

13,600 enrolled

Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

NCT07501871 2026-03-30

DMTA-CH

80 enrolled

Neoplasms

NCT07495735 2026-03-27

Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma

400 enrolled

Phase 2 Not yet recruiting

Carcinoma, Hepatocellular

NCT07472478 2026-03-16

GIVEN

32 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07447440 2026-03-11

RESOLBE

60 enrolled

BreastOther

Breast Neoplasms, Neoplasms, Obesity

NCT06249880 2026-03-09

Pediatric Normative Markerless Movement Analysis

LymphoidOther hematologic neoplasm

40 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07457099 2026-03-09

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

85 enrolled

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06896370 2026-02-25

An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori

3,000 enrolled

Stomach Neoplasms, Helicobacter Infections

NCT06378346 2026-02-23

GU-01

60 enrolled

Prostatic Neoplasms

NCT06192719 2026-02-18

EULAT

15,000 enrolled

Phase 4 Not yet recruiting

Cholelithiasis, Gallbladder Neoplasms

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

25 enrolled

Gynecologic

Endometrial Neoplasms

NCT05504681 2026-02-17

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

200 enrolled

Neurocognitive Disorders

NCT07410247 2026-02-13

MPN Childhood Registry

Phase 2 Not yet recruiting

500 enrolled

Myeloid

Childhood Myeloproliferative Neoplasms

NCT07405476 2026-02-12

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

38 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02677961 2026-02-11

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

1,500 enrolled

Sarcoma

Bone Neoplasms, Sarcoma, Neoplasms, Connective and Soft Tissue

NCT06629038 2026-02-11

Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model

40 enrolled

Mouth Neoplasms

NCT07400354 2026-02-10

The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota

300 enrolled

Stomach Neoplasms

NCT03516617 2026-02-09

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

LymphoidOther hematologic neoplasm

120 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06733350 2026-02-09

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Suspended

600 enrolled

Prostatic Neoplasms

NCT07177742 2026-02-06

Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis

260 enrolled

Colorectal Neoplasms

NCT07391007 2026-02-05

Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases

200 enrolled

Colorectal Liver Metastases

NCT03059485 2026-02-04

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Other hematologic neoplasm

82 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT05894083 2026-02-02

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

150 enrolled

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

NCT05061342 2026-01-27

TQ-BIRD

5,000 enrolled

Phase NA Active not recruiting

Neoplasms

NCT02492607 2026-01-26

LORD

2,500 enrolled

Phase EARLY_PHASE1 Recruiting

Carcinoma, Intraductal, Noninfiltrating

NCT07025226 2026-01-26

Senolytics

10 enrolled

CNS

Glioma

NCT06718010 2026-01-21

The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer

120 enrolled

Breast Neoplasms

NCT07353840 2026-01-20

T-START-CR

160 enrolled

Lymphoid

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT03180268 2026-01-14

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

163 enrolled

CNS

Meningioma

NCT02870907 2026-01-07

RB SFCE 09

195 enrolled

Other solid neoplasm

Retinoblastoma

NCT05717166 2025-12-31

SABR-SYNC

180 enrolled

Neoplasm Metastasis

NCT07310186 2025-12-30

Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy

200 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00165256 2025-12-29

Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

158 enrolled

Carcinoma, Intraductal, Noninfiltrating

NCT06378866 2025-12-26

DIVINE

532 enrolled

Prostatic Neoplasms

NCT07272187 2025-12-09

EURAGIL

138 enrolled

Endocrine

Hyperaldosteronism, Insulinoma

NCT07148193 2025-12-08

PROSa+

1,600 enrolled

Sarcoma

Neoplasms, Sarcoma

NCT07269535 2025-12-08

A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma

500 enrolled

Leiomyoma

NCT07250100 2025-11-26

MICROPAC

300 enrolled

Phase EARLY_PHASE1 Recruiting

Pancreatic Neoplasms

NCT07239544 2025-11-20

Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines

Active not recruiting

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03594630 2025-11-06

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

120 enrolled

Rectal Neoplasms

NCT05541016 2025-11-04

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

455 enrolled

Carcinoma, Oropharyngeal Neoplasms

NCT04519879 2025-10-29

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

133 enrolled

NCT02882282 2025-10-23

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Phase 2 Completed

15 enrolled 8 charts